CP CTT PHARMACEUTICAL HOLDINGS, INC. Stock: price and insider trades · United States · SEC (Form 4)Source id SEC:ctt-pharmaceutical-holdings-inc-f0cd91 US · SEC (Form 4) Mcap US$2.9M Track the CTT PHARMACEUTICAL HOLDINGS, INC. share price and the full insider trade history of the company, a listed equity based in United States. Shares are quoted on the US market, under the authority of SEC (Form 4). Market capitalisation: €2.9m. The latest transaction was filed on 10 September 2026 (Acquisition). Among the most active insiders: CTT PHARMACEUTICAL HOLDINGS, INC.. Every trade is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ Sigma AI Analysis Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 10 September 2026
All Executives59 Thresholds0 Prospectus0 Other0
Declarations 59 total
▲ CEO · Executives · 10 Sept 2026
3,500 shares @ US$0.05 CTTH SEC:0001035422-26-000011:0
Canonical exit: 9 Dec 2026 (T+90) ▲ CEO · Executives · 4 Sept 2026
9,800 shares @ US$0.0489 0.016% mcap 0.6% of flow CTTH SEC:0001035422-26-000010:0
Canonical exit: 3 Dec 2026 (T+90) ▲ CEO · Executives · 31 Aug 2026
3,500 shares @ US$0.049 0.0059% mcap 0.2% of flow CTTH SEC:0001035422-26-000008:0
Canonical exit: 29 Nov 2026 (T+90) ▲ CEO · Executives · 24 Aug 2026
2,100 shares @ US$0.055 0.0035% mcap 0.1% of flow CTTH SEC:0001035422-26-000007:0
Canonical exit: 22 Nov 2026 (T+90) ▲ CEO · Executives · 20 Aug 2026
11,500 shares @ US$0.045 0.015% mcap 0.7% of flow CTTH SEC:0001035422-26-000006:0
Canonical exit: 18 Nov 2026 (T+90) ▲ CEO · Executives · 19 Aug 2026
10,000 shares @ US$0.059 0.017% mcap 0.8% of flow CTTH SEC:0001035422-26-000005:0
Canonical exit: 17 Nov 2026 (T+90) ▲ CEO · Executives · 14 Aug 2026
1,800 shares @ US$0.062 0.0029% mcap 0.1% of flow CTTH SEC:0001035422-26-000004:0
Canonical exit: 12 Nov 2026 (T+90) ▲ CEO · Executives · 7 Aug 2026
7,700 shares @ US$0.065 0.013% mcap 0.7% of flow CTTH SEC:0001035422-26-000001:0
Canonical exit: 5 Nov 2026 (T+90) ▲ CEO · Executives · 17 Dec 2025
8,300 shares @ US$0.055 0.5% of flow CTTH SEC:0001035422-25-000018:0
Canonical exit: 17 Mar 2026 (T+90) ▲ Director · Executives · 20 Nov 2025
200,000 shares @ US$0.04 8.3% of flow CTTH SEC:0001035422-25-000017:0
Canonical exit: 18 Feb 2026 (T+90) ▲ CEO · Executives · 20 Nov 2025
62,900 shares @ US$0.04 2.6% of flow CTTH SEC:0001035422-25-000016:0
Canonical exit: 18 Feb 2026 (T+90) ▲ CEO · Executives · 31 Oct 2025
7,000 shares @ US$0.06 0.5% of flow CTTH SEC:0001035422-25-000015:0
Canonical exit: 29 Jan 2026 (T+90) ▲ CEO · Executives · 23 Sept 2025
6,815 shares @ US$0.06 0.5% of flow CTTH SEC:0001035422-25-000014:0
Canonical exit: 22 Dec 2025 (T+90) ◆ CEO · Executives · 1 Aug 2025
750,000 shares @ US$0.04 38.8% of flow CTTH SEC:0001035422-25-000013:0
▲ CEO · Executives · 2 Aug 2025
44,085 shares @ US$0.045 2.6% of flow CTTH SEC:0001035422-25-000013:1
Canonical exit: 31 Oct 2025 (T+90) ▲ CEO · Executives · 1 Aug 2025
15,800 shares @ US$0.035 0.7% of flow Shares Acquired SEC:0001035422-25-000011:0
Canonical exit: 30 Oct 2025 (T+90) ▲ CEO · Executives · 8 Jul 2025
8,000 shares @ US$0.03 0.3% of flow Shares Acquired SEC:0001035422-25-000010:0
Canonical exit: 6 Oct 2025 (T+90) ▲ CEO · Executives · 26 Jun 2025
39,600 shares @ US$0.025 1.1% of flow Shares Acquired SEC:0001035422-25-000009:0
Canonical exit: 24 Sept 2025 (T+90) ▲ CEO · Executives · 23 Jun 2025
16,100 shares @ US$0.025 0.5% of flow Shares Acquired SEC:0001035422-25-000008:0
Canonical exit: 21 Sept 2025 (T+90) ▲ CEO · Executives · 13 Jun 2024
54,798 shares @ US$0.025 1.8% of flow CTTH SEC:0001035422-25-000007:0
Canonical exit: 11 Sept 2024 (T+90) ▲ CEO · Executives · 9 Jun 2025
82,158 shares @ US$0.05 5.0% of flow CTTH SEC:0001035422-25-000006:0
Canonical exit: 7 Sept 2025 (T+90) ▲ CEO · Executives · 9 Apr 2025
9,984 shares @ US$0.065 0.9% of flow CTTH SEC:0001035422-25-000005:0
Canonical exit: 8 Jul 2025 (T+90) ▲ CEO · Executives · 31 Mar 2025
15,510 shares @ US$0.05 1.1% of flow CTTH SEC:0001035422-25-000004:0
Canonical exit: 29 Jun 2025 (T+90) ▲ CEO · Executives · 11 Mar 2025
5,400 shares @ US$0.06 0.4% of flow CTTH SEC:0001035422-25-000003:0
Canonical exit: 9 Jun 2025 (T+90) ▲ CEO · Executives · 7 Mar 2025
11,950 shares @ US$0.09 1.5% of flow CTTH SEC:0001035422-25-000002:0
Canonical exit: 5 Jun 2025 (T+90) 25 of 59 declarations
Load more (34 remaining) 关于 CTT PHARMACEUTICAL HOLDINGS, INC. CTT PHARMACEUTICAL HOLDINGS, INC. 是一家专注于药品开发和商业化的公司。该公司在纳斯达克上市，股票代码为CTT。